Electromagnetic Treatment for Ischemic Stroke Recovery

Inclusion Criteria: 1. mRS score of 3 or 4. 2. FMA-UE score between 10-45 (inclusive) of impaired limb. 3. SAFE score \>0. 4. Age 22 to 80 years of age (inclusive). 5. Diagnosed with an ischemic stroke, confirmed by CT4 or MRI5 imaging. 6. First ever ischemic stroke, or a recurring ischemic stroke6 occurring at least 3 months after the previous stroke (any stroke), without residual neurological impairment or disability before current stroke. 7. Four to 21 days from stroke onset (or last known well). 8. Pre-stroke mRS of 0. 9. Able to sit with the investigational device for 40 consecutive minutes, in the opinion of the investigator or designee. 10. Can follow a 3-step command, such as "take the paper, fold it in half, and return it to me". 11. Willingness to participate in an exercise activity during study intervention sessions. 12. Availability of a relative or other caregiver able to assist in operating an application installed on a mobile device, including a video call, and assist the participant with the exercising program. 13. If female, not pregnant (as confirmed by a urine or a blood test, or as determined by an official medical document) or breastfeeding and with no ability to become pregnant or on an acceptable method of contraception during the study 14. Informed consent signed by subject. Exclusion Criteria: 1. Hemineglect impairment (NIHSS item 11, score \>0). 2. Implanted active electronic or passive MR-incompatible devices. 3. Pre-existing major neurological condition (eg, Alzheimer's disease, Parkinson's disease, multiple sclerosis, traumatic brain injury, spinal cord injury) or pre-existing physical limitation that would interfere significantly with the subject's participation in the study and/or confound neurological or functional evaluation. 4. Active epilepsy or currently taking anti-epileptic medication (indicated for the treatment of a seizure disorder), or any epileptic seizure in the last 5 years 5. Significant visual disturbances, pre-existing or resulting from the index stroke, that cannot be corrected and that would interfere significantly with the subject's participation in the study and/or confound neurological or functional evaluation. 6. Unstable serious illness/condition (eg, active cancer, severe heart failure, active major psychiatric condition) or life expectancy of less than 12 months. 7. A known severe allergic reaction to acrylic-based adhesives. 8. Alcohol abuse and/or illicit drug abuse in the past 6 months, which is likely to influence ability to fully participate in the trial. 9. Participation in another trial that would conflict with the current study or clinical endpoint interference may occur. 10. Employee of the Sponsor. 11. Prisoner.